000 01217 a2200385 4500
005 20250513201530.0
264 0 _c20000127
008 200001s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.54.1.244
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPal, P K
245 0 0 _aBotulinum toxin A as treatment for drooling saliva in PD.
_h[electronic resource]
260 _bNeurology
_cJan 2000
300 _a244-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBotulinum Toxins, Type A
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xcomplications
650 0 4 _aParotid Gland
_xdrug effects
650 0 4 _aSaliva
_xdrug effects
650 0 4 _aSialorrhea
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aCalne, D B
700 1 _aCalne, S
700 1 _aTsui, J K
773 0 _tNeurology
_gvol. 54
_gno. 1
_gp. 244-7
856 4 0 _uhttps://doi.org/10.1212/wnl.54.1.244
_zAvailable from publisher's website
999 _c10591494
_d10591494